Trending Stocks
AI-Detected Trends Before They Happen. Daily short-term research ideas with clear reasoning and a live model portfolio of trending stocks.
Get daily or weekly stock research ideas.
Research content for general circulation. Not individualized advice.
Ideas Cumulative PerformanceCompounded
Currently active model ideas with performance tracking
Fresh 2026-05-28 earnings catalyst showed record Q1 revenue of $43.8B and record EPS, with guidance provided. AI infrastructure evidence is strong, including $64B AI server orders, $43B backlog, raised AI server shipment guidance to $20B, and raised full-year revenue/EPS guidance; stock rose about 97% over 21 trading days.
Legitimate near-term momentum setup supported by Q1 revenue growth of 85%, raised full-year guidance, a $300M USDA agreement, Cleveland-Cliffs partnership, and strong U.S. commercial/government AIP demand. Technicals confirm strength, with a new 21-day high at 156.46 and a sharp 14% gain over the last five sessions.
Q1 2026 beat and raised full-year guidance, with EPS of $0.27 versus $0.22 expected. AI coding agents, AI experimentation, supply-chain security, and AI governance releases are resonating with software investors; stock rose about 69.6% over 21 trading days.
Recent Q1 FY2027 results drove a breakout, with revenue up 13.5% YoY to $2.542B and subscription revenue up 14.3%. Workday beat non-GAAP earnings and revenue, continues to push AI-linked product news and partnerships, and the stock is up about 19% over 21 trading days after clearing its prior range high.
Browse by Sector
Explore stock research ideas organized by industry sectors. Discover companies and investment opportunities across different market segments.
Best Recent Ideas
Top recent model ideas from our AI-powered pipeline with tracked outcomes
Jyong Biotech (MENS) has surged from $7.50 to over $23 post-IPO, showing exceptional short-term strength and clear higher highs/lows. Momentum traders targeting quick gains could capitalize on further follow-through, though underlying liquidity and trial risks remain significant.
USARW exhibits a strong short-term breakout with a 218% surge over 21 trading days well above its 21-day moving average and the upper Bollinger Band, signaling significant momentum. Despite elevated overbought risk, the strong technical strength and sector demand cyclicality make USARW a compelling hot idea for near-term trading gains with cautious risk management.
High-risk semiconductor test beneficiary with an imminent catalyst: multiple recent production orders (FOX wafer-level systems, silicon-photonics and GaN programs), reinstated H2 revenue guidance ($25–30M) and a sharp rebound (~+31% from March 30 to April 1) into the 2026-04-07 Q3 earnings release create a classic near-term event/momentum setup.
AeroVironment has outperformed its sector recently and sits on a technical base around $180–195 ahead of a June earnings release that could validate its strong profitability and revenue growth outlook. The BlueHalo merger adds a fresh growth narrative in drone defense, and the risk/reward looks favorable given the stock’s low leverage and positive analyst sentiment.
Model Ideas History
Complete track record of all published ideas with transparent outcomes.
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| May 29 | Jun 5 | DELL | Dell Technologies Inc. | Fresh 2026-05-28 earnings catalyst showed record Q1 revenue of $43.8B and record EPS, with guidance provided. AI infrastructure evidence is strong, including $64B AI server orders, $43B backlog, raised AI server shipment guidance to $20B, and raised full-year revenue/EPS guidance; stock rose about 97% over 21 trading days. | Active | +0.0% |
| May 29 | Jun 5 | PLTR | Palantir Technologies Inc. | Legitimate near-term momentum setup supported by Q1 revenue growth of 85%, raised full-year guidance, a $300M USDA agreement, Cleveland-Cliffs partnership, and strong U.S. commercial/government AIP demand. Technicals confirm strength, with a new 21-day high at 156.46 and a sharp 14% gain over the last five sessions. | Active | +0.0% |
| May 29 | Jun 5 | FROG | JFrog Ltd. | Q1 2026 beat and raised full-year guidance, with EPS of $0.27 versus $0.22 expected. AI coding agents, AI experimentation, supply-chain security, and AI governance releases are resonating with software investors; stock rose about 69.6% over 21 trading days. | Active | +0.0% |
| May 29 | Jun 5 | WDAY | Workday, Inc. | Recent Q1 FY2027 results drove a breakout, with revenue up 13.5% YoY to $2.542B and subscription revenue up 14.3%. Workday beat non-GAAP earnings and revenue, continues to push AI-linked product news and partnerships, and the stock is up about 19% over 21 trading days after clearing its prior range high. | Active | +0.0% |
| May 28 | Jun 4 | STX | Seagate Technology Holdings plc | AI storage demand supports a strong trade: stock rose about 39% over 21 trading days, Q3 beat guidance with record margins and nearly $1B free cash flow, and nearline capacity is fully allocated through calendar 2026. | Active | -0.1% |
| May 28 | Jun 4 | MU | Micron Technology, Inc. | Strong near-term momentum and fundamentals: fiscal Q3 revenue guided to a record $33.5B, gross margin around 81%, AI-driven DRAM/NAND demand remains tight, and the stock is up about 81% over 21 trading days. | Active | +5.1% |
| May 28 | Jun 4 | USAR | USA Rare Earth Inc | Speculative rare-earth momentum with concrete catalysts: stock rose about 27% over 21 trading days, supported by commissioning commercial magnet production, first commercial yttrium pour, a 15-year offtake deal, and up to $19.3M in federal funding. | Active | -0.6% |
| May 27 | Jun 3 | CRWD | CrowdStrike Holdings, Inc. | Cybersecurity momentum candidate with shares up about 43% over 21 trading days, $5.25B ending ARR, record $1.01B net new ARR, broad product/partner announcements, and a near-term Q1 FY27 earnings catalyst on 2026-06-03. | Active | +13.3% |
| May 27 | Jun 3 | RKLB | Rocket Lab USA, Inc. | Space momentum and catalyst flow are strong: record Q1 revenue of $200.3M, better-than-expected results, strong Q2 outlook, $2.2B backlog, new Electron/Neutron bookings, a $90M U.S. Space Force award, and shares up 88% over 21 trading days. | Active | -4.5% |
| May 27 | Jun 3 | LLY | Eli Lilly and Company | Large-cap healthcare momentum with strong fundamentals: Q1 revenue grew 56% to $19.8B, full-year guidance was raised, Mounjaro and Zepbound demand remains strong, and recent FDA/pipeline/acquisition news keeps catalyst flow active. | Active | +2.0% |
How It Works
Our proprietary pipeline combines AI-powered analysis with systematic validation. Learn more about our methodology and check out our FAQ for details.
AI Analysis
Our pipeline continuously monitors news, earnings reports, technical indicators, and price action across thousands of stocks.
Multi-Layer Filtering
Ideas pass through multi-agent analysis framework: fundamental and news screening, technical confirmation, and risk assessment.
Publication & Alerts
Validated model ideas are published with clear reasoning. You may opt in to receive publication alerts.
Frequently Asked Questions
Everything you need to know about Trending Stocks.
Important Legal Disclaimer
Not Investment Advice: All content on this platform is provided for informational and educational purposes only. Nothing on this site constitutes investment advice, financial advice, trading advice, or any other sort of advice.
No Guarantees: Past performance is not indicative of future results. All investments carry risk, and you may lose some or all of your capital.
Do Your Own Research: You are solely responsible for your own investment decisions. Always conduct thorough research and consider consulting with a qualified financial advisor.
Data Accuracy: While we strive for accuracy, we make no warranties about the completeness, reliability, or accuracy of information provided.
By using this service, you acknowledge that you have read and agree to our Terms of Service and Privacy Policy.